Main menu button

CorTec gains Mangold Invest as new investor and plans the entry in clinical studies

In its third financing round, the medical device company CorTec received growth capital from Mangold Invest. The recently completed investment supports CorTec to provide patients with personalized therapies for neurological diseases. With Mangold Invest, the young medical device company located in Freiburg gained a new investor that accompanies this way.

The managing partners of CorTec, Dr. Jörn Rickert and Dr. Martin Schüttler, welcome the composition of the financing round. “It is a rarity to find an investor like Prof. Dr. Klaus Mangold, who has a big experience and international network as well as a strong relation to Freiburg”, comments Dr. Jörn Rickert. “The willingness of our existing investors to participate in the round furthermore underlines the potential of our technology in a fast growing market as well as the quality of our work accomplished so far”, complements Dr. Martin Schüttler.

Client: CorTec
Industry: Life Science
Assignment: Sellside
Caspar Graf Stauffenberg
Caspar Graf Stauffenberg LinkedIn
Managing Partner